Insider Transactions in Q3 2022 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
|
Sep 22
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.77%
|
$1,669,500
$84.66 P/Share
|
|
Sep 22
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.18%
|
-
|
|
Sep 22
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
|
Sep 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$605,250
$90.94 P/Share
|
|
Sep 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
|
Sep 06
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$644,538
$89.0 P/Share
|
|
Sep 06
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
|
Aug 15
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
|
Aug 15
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.77%
|
$2,067,000
$104.79 P/Share
|
|
Aug 15
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.2%
|
-
|
|
Aug 15
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
|
Aug 09
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-1.74%
|
$753,168
$104.81 P/Share
|
|
Aug 09
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|
|
Aug 09
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$706,125
$105.01 P/Share
|
|
Aug 09
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
|
Aug 05
2022
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Direct |
4,811
-18.46%
|
$495,533
$103.66 P/Share
|
|
Aug 02
2022
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
1,000
-5.02%
|
$102,000
$102.49 P/Share
|
|
Jul 14
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
9,500
+0.28%
|
-
|
|
Jul 14
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
9,500
-5.69%
|
-
|
|
Jul 14
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
19,875
-3.68%
|
$1,888,125
$95.77 P/Share
|
|
Jul 14
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,375
+13.59%
|
$1,028,125
$35.2 P/Share
|
|
Jul 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
3,675
-3.57%
|
$356,475
$97.6 P/Share
|
|
Jul 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
3,675
+3.44%
|
$128,625
$35.2 P/Share
|
|
Jul 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,725
-9.71%
|
$652,325
$97.6 P/Share
|
|
Jul 08
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,725
+8.85%
|
$235,375
$35.2 P/Share
|
|
Jul 07
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
6,100
+3.49%
|
-
|
|
Jul 07
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct |
2,032
+5.43%
|
-
|
|
Jul 05
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-3.46%
|
$687,990
$95.9 P/Share
|
|
Jul 05
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.34%
|
$260,712
$36.75 P/Share
|